Cell type-specific effects of Rb deletion in the murine retina
Open accessAbstract
Certain cells of the human retina are extremely sensitive to loss of function of the retinoblastoma tumor suppressor gene RB. Retinoblastomas develop early in life and at high frequency in individuals heterozygous for a germ-line RB mutation, and sporadic retinoblastomas invariably have somatic mutation in the RB gene. In contrast, retinoblastomas do not develop in Rb+/- mice. Although retinoblastoma is thought to have developmental origins, the function of Rb in retinal development has not been fully characterized. Here we studied the role of Rb in normal retinal development and in retinoblastoma using conditional Rb mutations in the mouse. In late embryogenesis, Rb-deficient retinas exhibited ectopic S-phase and high levels of p53-independent apoptosis, particularly in the differentiating retinal ganglion cell layer. During postnatal retinal development, loss of Rb led to more widespread retinal apoptosis, and adults showed loss of photoreceptors and bipolar cells. Conditional Rb mutation in the retina did not result in retinoblastoma formation even in a p53-mutant background. However, on a p107- or p130-deficient background, Rb mutation in the retina caused retinal dysplasia or retinoblastoma.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Failure to exit the cell cycle properly during differentiation is a mechanism by which mutant Rb cells can begin to become tumour cells.
“indicating that failure to exit the cell cycle properly as they differentiate is a mechanism by which mutant Rb cells can begin to become tumour cells50,51,55–57.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [51]
Cells that lose RB before cell cycle exit and retain differentiation ability may have increased capacity to re-enter the cell cycle and initiate cancer with certain stimuli.
“cells that lose RB function before cell cycle exit and retain the ability to differentiate might also exhibit an increased capacity to re-enter the cell cycle and initiate cancer in the presence of certain stimuli”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [51]
Rb inactivation in mouse retinal progenitors causes cell-autonomous defects in cell cycle exit, differentiation defects, proliferation in differentiating cells, and increased cell death.
“Rb inactivation in mouse retinal progenitors results in cell-autonomous defects in cell cycle exit, specific differentiation defects, proliferation in differentiating cells and increased cell death.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 62 · Cited by 222
- Authors
- MacPherson, D., Sage, J., Kim, T., Ho, D., McLaughlin, M. E., & Jacks, T.
- Affiliations
- Howard Hughes Medical Institute (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2004-07-01
- Volume
- 18
- Issue
- 14
- Pages
- 1681-1694
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- PMC
- PMC478190
- OpenAlex
- W2127946085
- Cited by
- 222
- References
- 62
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 4 · 2023: 6 · 2022: 7 · 2021: 4 · 2020: 4 · 2019: 5 · 2018: 6 · 2017: 10 · 2016: 6 · 2015: 5 · 2014: 4 · 2013: 12 · 2012: 17
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinal Development and Disorders
- Health Sciences › Medicine › Ophthalmology › Ocular Oncology and Treatments
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- retinoblastoma, retinoblastoma protein, retinal development, retinal apoptosis, p53-independent apoptosis, retinal ganglion cells, photoreceptor loss, bipolar cells, retinal dysplasia, p107, p130
- MeSH terms
- Animals, Crosses, Genetic, Disease Models, Animal, Immunohistochemistry, Mutation, Nuclear Proteins, Proteins, Retina, Retinal Ganglion Cells, Retinoblastoma, Immunoblotting, Blotting, Western, Genes, Retinoblastoma, Apoptosis, Cyclin D1, In Situ Nick-End Labeling, Retinoblastoma-Like Protein p130, Retinoblastoma-Like Protein p107, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review